Life, limb or off-label recombinant VIIa use in the setting of limited blood assets
Year: 2013
Type: article
Study design: Case Report
Source: Blood Coagulation & Fibrinolysis
Authors: Marcus E. Carr, Brian Vickaryous
Institution: Pfizer (United States)
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Pfizer, Novo Nordisk
OpenAlex ID: W2329906315